Eli Lilly Shares Slip After Analyst Flags a Foundayo Liver Case in FDA Database
Eli Lilly shares dropped about 3% on Monday after an Evercore ISI analyst flagged a hepatic failure report tied to Foundayo in the FDA Adverse Event Reporting System. The case involved a 56-year-old man, with the event possibly occurring on or before April 15 and reported to regulators on April 30. The analyst placed the incident in the context of …